Trial Profile
Phase III Trial Assessing the Interest of a Maintenance Chemotherapy Combining Docetaxel (Taxotere) 5-FU After Induction Treatment by Aintensive Chemotherapy for Inflammatory Breast Cancers
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Oct 2019
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Cyclophosphamide; Epirubicin; Fluorouracil
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms FNCLCC-PEGASE 07
- Sponsors UNICANCER
- 05 Nov 2010 New trial record.